Botox migraine treatment to be assessed by NICE
Page 1 of 1
Botox migraine treatment to be assessed by NICE
This can only be good news.
__________________________________________________________________________________
By Tom Moberly, 11 August 2011
Treatment of migraine with botulinum toxin type A is to be assessed by NICE, details of the institute's latest work programme reveal.
A technology appraisal will assess ‘the clinical and cost effectiveness of botulinum toxin type A within its licensed indication for the prophylaxis of headaches associated with chronic migraine’.
After botulinum toxin was licensed for treating chronic migraine, RCGP headache champion Dr David Kernick warned in GP that practical and funding issues would initially limit availability of the treatment. However, if botulinum toxin type A is accepted for the treatment of migraine by NICE, NHS services will have a legal duty to provide access to it.
http://www.gponline.com/News/article/1084421/botox-migraine-treatment-assessed-nice/
__________________________________________________________________________________
By Tom Moberly, 11 August 2011
Treatment of migraine with botulinum toxin type A is to be assessed by NICE, details of the institute's latest work programme reveal.
A technology appraisal will assess ‘the clinical and cost effectiveness of botulinum toxin type A within its licensed indication for the prophylaxis of headaches associated with chronic migraine’.
After botulinum toxin was licensed for treating chronic migraine, RCGP headache champion Dr David Kernick warned in GP that practical and funding issues would initially limit availability of the treatment. However, if botulinum toxin type A is accepted for the treatment of migraine by NICE, NHS services will have a legal duty to provide access to it.
http://www.gponline.com/News/article/1084421/botox-migraine-treatment-assessed-nice/
Similar topics
» Canada approves BOTOX® as prophylactic treatment for chronic migraine
» Migraine Treatment Topiramate May Have Benefit As A Weight-Loss Drug
» PuraMed BioScience, Inc. Outlines 2012 Marketing Plans for Clinically Tested Migraine Treatment LipiGesic(R)
» CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
» NEW TREATMENT _ IMPLANT MAY END MIGRAINE MISERY
» Migraine Treatment Topiramate May Have Benefit As A Weight-Loss Drug
» PuraMed BioScience, Inc. Outlines 2012 Marketing Plans for Clinically Tested Migraine Treatment LipiGesic(R)
» CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
» NEW TREATMENT _ IMPLANT MAY END MIGRAINE MISERY
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
|
|
Thu Mar 30, 2017 9:04 am by Sarah
» Facebook group - now set up
Fri Feb 24, 2017 7:43 am by Tee
» cluster headache
Wed Feb 15, 2017 3:51 pm by Heregailing
» Your view on migraines and social media
Fri Feb 10, 2017 4:17 am by Tee
» Fats and Chronic Pain/Headaches
Thu May 19, 2016 10:52 pm by Sarah
» National hospital - London
Sun Jan 10, 2016 3:18 pm by pīwakawaka
» Just saying Hello
Sun Jan 10, 2016 3:12 pm by pīwakawaka
» Botox for harmeplegic migraines
Thu Sep 24, 2015 10:59 pm by Robyn17
» Hello and thank you
Mon May 25, 2015 12:55 am by ajdesq